Regeneron Pharmaceuticals, Inc. (REGN) has 12 identified peers for comparison in the Healthcare sector. Peers include ALNY, APLS, ARWR, BGNE, BMRN, CRSP and others.
REGN has a market capitalization of $78.5B, compared to an average peer market cap of $13.12B. REGN is significantly larger than its average peer.
